H James Dallas Acquires 1,693 Shares of Centene Co. (NYSE:CNC) Stock

Centene Co. (NYSE:CNC - Get Free Report) Director H James Dallas purchased 1,693 shares of the stock in a transaction dated Monday, December 16th. The stock was bought at an average cost of $59.01 per share, with a total value of $99,903.93. Following the transaction, the director now owns 1,693 shares in the company, valued at $99,903.93. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Centene Price Performance

Shares of Centene stock opened at $57.81 on Wednesday. The stock's fifty day moving average is $61.51 and its 200 day moving average is $68.41. Centene Co. has a one year low of $55.03 and a one year high of $81.42. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The stock has a market cap of $29.18 billion, a P/E ratio of 10.04, a P/E/G ratio of 0.78 and a beta of 0.46.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Park Place Capital Corp raised its stake in Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company's stock worth $29,000 after acquiring an additional 357 shares during the period. WR Wealth Planners LLC raised its position in shares of Centene by 41.4% during the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company's stock valued at $31,000 after purchasing an additional 137 shares during the period. Chris Bulman Inc purchased a new position in shares of Centene during the 2nd quarter valued at $33,000. Crewe Advisors LLC increased its stake in Centene by 174.3% in the 2nd quarter. Crewe Advisors LLC now owns 683 shares of the company's stock worth $45,000 after buying an additional 434 shares in the last quarter. Finally, Private Trust Co. NA raised its holdings in Centene by 75.3% during the third quarter. Private Trust Co. NA now owns 773 shares of the company's stock valued at $58,000 after acquiring an additional 332 shares during the period. 93.63% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth


Trump’s Secret Manhattan Project
On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just spent six months investigating this...and what I found is shocking.
Click here and I’ll show you exactly how to position your money


Several research analysts have recently issued reports on the stock. Sanford C. Bernstein dropped their target price on shares of Centene from $96.00 to $88.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 30th. Wells Fargo & Company reduced their target price on Centene from $91.00 to $90.00 and set an "overweight" rating for the company in a report on Monday, November 4th. Robert W. Baird lowered their price target on Centene from $83.00 to $66.00 and set a "neutral" rating on the stock in a report on Friday, October 25th. Jefferies Financial Group downgraded Centene from a "hold" rating to an "underperform" rating and reduced their price objective for the stock from $68.00 to $52.00 in a report on Tuesday, December 10th. Finally, StockNews.com cut shares of Centene from a "strong-buy" rating to a "buy" rating in a research note on Monday, October 28th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $80.92.

Check Out Our Latest Stock Report on Centene

About Centene

(Get Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

See Also

Insider Buying and Selling by Quarter for Centene (NYSE:CNC)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Centene?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Centene and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles